LeMaitre Vascular, Inc. (LMAT) Earnings Call Analysis

NASDAQ · Healthcare · Medical Instruments & Supplies

21/25

Growth 4 Margin 5 Expansion 5 Platform 2 Financial 5

latest quarter score

Earnings Reports

21
LeMaitre Vascular (LMAT) Q2 2026: Artograph Surges 34%, Driving Europe Gross Margin Expansion
August 05, 2026
22
Lumate Vascular (LMAT) Q1 2026: Gross Margin Expands 350bps as Autograph Drives Premium Mix
May 06, 2026
21
LeMaitre Vascular (LMAT) Q4 2025: Price Increases Drive 9% Organic Growth as International Expansion Accelerates
February 26, 2026
21
LeMaitre Vascular (LMAT) Q3 2025: 300bps Margin Expansion Signals Pricing Power and Biologics Upside
November 07, 2025
21
LeMaitre Vascular (LMAT) Q2 2025: 15% Organic Growth Anchored by 8% Price, Guidance Raised on International Momentum
August 06, 2025
19
LeMaitre Vascular (LMAT) Q1 2025: Sales Force Expands 27 Reps, Lifting Organic Growth to 13%
July 03, 2025
LeMaitre Vascular (LMAT) Q4 2024: 14% Sales Growth Driven by Salesforce Expansion and International Market Penetration
February 27, 2025

Browse all companies